Toward unshielded MRI for improved safety and access
Project Number1K99EB035647-01
Contact PI/Project LeaderKAZEMIVALIPOUR, EHSAN
Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Magnetic resonance imaging (MRI) is a valuable non-invasive imaging technology, but it is expensive and out of
reach for many centers, especially those in rural areas of the US and developing countries. MRI’s significant
siting requirements for safe operation can double or triple the cost of systems, and therefore are a major barrier
to access. The growing popularity of portable MRI systems highlights the demand for more accessible and
affordable MRI technology, but these systems do not offer the same image quality and versatility as conventional
clinical scanners and remain specialized equipment dedicated to specific populations and conditions. This
proposal aims to advance the technology needed to dramatically reduce the siting burden of
conventional superconducting scanners (factor of ~2x), thus drastically improving patient access to
whole-body systems that are applicable to all populations and conditions.
The proposal introduces and validates a new approach combining passive and active radiofrequency
(RF) radiation cancellation in the far-field regime. We are developing the approach through a comprehensive
program of electromagnetic modeling, system design, and experimental verification to solve the problem of
transmit Electromagnetic Compatibility (EMC) in MRI without using a Faraday cage. We leverage 20 years of
research and expertise in electromagnetic modeling and parallel transmission (pTx) technology to tackle this
new and important problem that has received little-to-no attention from the engineering community.
Importantly, this proposal aligns with my research background and interests and was specifically
designed in conjunction with my mentors to enable me to become an independent investigator. A K99/R00 award
would help me jumpstart a bioengineering career focused on addressing clinically important problems through
innovative technological approaches. Following the R00 phase, I plan to continue my career at the cutting edge
of technology development for MRI, maximizing the impact on patient health and accessibility. My ultimate goal
is to develop into an independent investigator who creates and applies new technology to improve the
accessibility and affordability of MRI while maintaining high standards of safety and quality for patient care.
The Martinos Center at Massachusetts General Hospital provides an ideal environment and infrastructure
to execute the proposed research strategy. The Center offers extensive hardware and computing resources, as
well as several large-bore MR scanners that will facilitate the technical development of this proposal, aiming to
eliminate the need for a Faraday shielded cage. To facilitate my transition to independence, I have collaborated
with my mentors to design a training program that includes coursework, specialized seminars, and clinical
shadowing. During the K99 phase, I will be mentored by world-leading experts in MRI physics and hardware
development (Dr. Lawrence L. Wald), neuroradiology (Dr. Susie Yi Huang), and MRI RF coil development and
optimization (Dr. Bastien Guerin). Their expertise and mentorship will guide me in this project and my training.
Public Health Relevance Statement
NARRATIVE
Whole-body MRI scanners face limited accessibility due to their high expense and specific siting requirements,
which can substantially increase costs. MRI suites rely on a costly Faraday shielded room to eliminate image
artifacts caused by external radio waves as well as reduce radio wave emission which can disrupt nearby hospital
equipment. We aim to enhance MRI accessibility and reduce expenses by replacing the Faraday shield with a
combination of strategically placed passive EM absorbers within the MRI bore and an active cancellation system
based on the parallel transmission (pTx) technology.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-May-2024
Project End Date
30-April-2026
Budget Start Date
01-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$133,176
Direct Costs
$124,750
Indirect Costs
$8,426
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$133,176
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K99EB035647-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K99EB035647-01
Patents
No Patents information available for 1K99EB035647-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K99EB035647-01
Clinical Studies
No Clinical Studies information available for 1K99EB035647-01
News and More
Related News Releases
No news release information available for 1K99EB035647-01
History
No Historical information available for 1K99EB035647-01
Similar Projects
No Similar Projects information available for 1K99EB035647-01